title: Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research Which areas to target? Which particle size to deliver? Which device to use?
authors.forename: Bart L
authors.initials: BL
authors.lastname: Rottier
authors.forename: Anne H
authors.initials: AH
authors.lastname: de Boer
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Duiverman
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D015195:Drug Design; D006801:Humans; D010316:Particle Size; D052638:Particulate Matter / Q000008:administration & dosage*
chemical_list: D000336:Aerosols; D000900:Anti-Bacterial Agents; D052638:Particulate Matter